Sponsor Pipeline

Pyrotech Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-11 NCT06244992
PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid…		 Trial sites expanded: 3 -> 6 locations
2026-08-11 NCT06244992
PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid…		 date change Primary completion pushed: 2025-12-31 -> 2027-09-30
2026-08-11 NCT06244992
PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid…		 date change Completion pushed: 2026-02-28 -> 2027-12-31
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-05 NCT07747155 A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PTT-621 in… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07747155 A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PTT-621 in… Ulcerative Colitis (UC) Not Yet Recruiting
Phase 1/2
NCT06244992 PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid… Locally Advanced or Metastatic Solid Tumors Recruiting
Disease Areas
Ulcerative Colitis (1)
Get alerts when Pyrotech Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free